{"timestamp": 1771602670.1243858, "value": {"ticker": "HRTX", "company_name": "Heron Therapeutics, Inc.", "short_name": "Heron Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 216386112, "float_shares": 128570133, "shares_outstanding": 183362522, "short_ratio": 21.75, "short_percent_of_float": 0.23799999, "shares_short": 35264370, "shares_short_prior": 34053061, "insider_percent_held": 0.00841, "institution_percent_held": 0.85910004, "total_cash": 55487000, "total_debt": 140443008, "total_revenue": 155096992, "revenue_growth": 0.165, "earnings_growth": 0, "profit_margins": -0.08755, "gross_margins": 0.66268, "operating_margins": -0.10711, "debt_to_equity": 943.52, "current_ratio": 2.557, "book_value": 0.038, "price_to_book": 31.055264, "operating_cashflow": -30187000, "free_cashflow": -33858876, "price": 1.1801, "52w_high": 2.68, "52w_low": 1.0, "avg_volume": 1723873, "avg_volume_10d": 1033240, "full_time_employees": 122, "audit_risk": 5, "overall_risk": 2}}